Publications by authors named "Judy B Tejon"
J Surg Case Rep
October 2024
Article Synopsis
- As FDA-approved Belzutifan shows promise in managing von Hippel-Lindau (VHL)-related lesions, questions arise about its effectiveness against non-VHL tumors that don't require immediate surgery.
- The follow-up report focuses on a VHL patient with a history of pulmonary mucosa-associated lymphoid tissue lymphoma, revisiting a case discussed in scientific literature around 10 years ago.
- The case underscores the challenges faced by VHL patients with additional non-VHL tumors and highlights the potential for targeted medical support.
